Literature DB >> 21761126

Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.

A Smithson1, C Chico, J Ramos, C Netto, M Sanchez, J Ruiz, R Porron, M T Bastida.   

Abstract

The purpose of this study was to evaluate the prevalence and clinical risk factors for quinolone resistance (QR) in E. coli strains from males with febrile urinary tract infection (FUTI). An ambispective cross-sectional study was performed in which we evaluated 153 males with a community FUTI caused by E. coli. Among the 153 FUTI episodes, 101 (66%) were due to quinolone susceptible E. coli strains while 52 (34%) were caused by QR E. coli strains. In the univariate analysis QR was associated with older age, higher Charlson scores, dementia, past UTI, urinary tract abnormalities, previous antibiotic use, particularly with fluoroquinolones (FQ), a healthcare-associated (HA)-UTI (HA-UTI) and to four of the components included in the definition of HA-UTI: hospital admission, nursing home residence, indwelling urethral catheter and invasive urinary instrumentation. In the multivariate analysis, HA-UTI (OR 3.82, 95% CI 1.3-11.24; P 0.015) and use of antimicrobials in the previous month (OR 5.82, 95% CI 2.3-14.88; P < 0.001) mainly with FQ (OR 13.97, 95% CI 2.73-71.53; P 0.002) were associated with QR. To have a HA-UTI and a previous use of FQ in the preceding month were strong risk factors for QR E. coli, and thus empirical antimicrobial treatment with quinolones should be avoided in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761126     DOI: 10.1007/s10096-011-1322-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.

Authors:  Joaquim Ruiz; Julián Gómez; Margarita M Navia; Anna Ribera; Josep M Sierra; Francesc Marco; Josep Mensa; Jordi Vila
Journal:  Diagn Microbiol Infect Dis       Date:  2002-04       Impact factor: 2.803

Review 2.  Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.

Authors:  Kurt G Naber; Fritz Sörgel
Journal:  Andrologia       Date:  2003-10       Impact factor: 2.775

3.  Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.

Authors:  Juan P Horcajada; Jordi Vila; Antonio Moreno-Martínez; Joaquim Ruiz; Jose Antonio Martínez; Miquel Sánchez; Eladio Soriano; Josep Mensa
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

4.  Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications.

Authors:  Sandra Mazzoli
Journal:  FEMS Immunol Med Microbiol       Date:  2010-02-17

5.  Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Juan C Alcalá; Jose M Cisneros; Fabio Grill; Antonio Oliver; Juan P Horcajada; Teresa Tórtola; Beatriz Mirelis; Gemma Navarro; María Cuenca; María Esteve; Carmen Peña; Ana C Llanos; Rafael Cantón; Alvaro Pascual
Journal:  Arch Intern Med       Date:  2008-09-22

Review 6.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

7.  The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.

Authors:  Ebbing Lautenbach; Joshua P Metlay; Xiangqun Mao; Xiaoyan Han; Neil O Fishman; Warren B Bilker; Pam Tolomeo; Mary Wheeler; Irving Nachamkin
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

8.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

9.  Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.

Authors:  R Colodner; I Kometiani; B Chazan; R Raz
Journal:  Infection       Date:  2008-01-12       Impact factor: 3.553

10.  Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis.

Authors:  Manuel Etienne; Pascal Chavanet; Louis Sibert; Frédéric Michel; Hervé Levesque; Bernard Lorcerie; Jean Doucet; Pierre Pfitzenmeyer; François Caron
Journal:  BMC Infect Dis       Date:  2008-01-30       Impact factor: 3.090

View more
  8 in total

1.  Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males.

Authors:  A Smithson; J Ramos; M T Bastida; S Bernal; N Jove; E Niño; N Msabri; R Porrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

2.  Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.

Authors:  W Ni; X Song; J Cui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-14       Impact factor: 3.267

3.  Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection.

Authors:  Gilho Lee
Journal:  Korean J Urol       Date:  2013-06-12

4.  Gram-negative Organisms from Patients with Community-Acquired Urinary Tract Infections and Associated Risk Factors for Antimicrobial Resistance: A Single-Center Retrospective Observational Study in Japan.

Authors:  Naoki Kanda; Hideki Hashimoto; Tomohiro Sonoo; Hiromu Naraba; Yuji Takahashi; Kensuke Nakamura; Shuji Hatakeyama
Journal:  Antibiotics (Basel)       Date:  2020-07-23

5.  Risk factors for quinolone-resistant Escherichia coli infection: a systematic review and meta-analysis.

Authors:  Dong-Mei Zhu; Qiu-Hong Li; Yan Shen; Qin Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-09       Impact factor: 4.887

6.  From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Authors:  Salam Abbara; Didier Guillemot; Christian Brun-Buisson; Laurence Watier
Journal:  Antibiotics (Basel)       Date:  2022-02-04

7.  Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012.

Authors:  Pär-Daniel Sundvall; Marie Elm; Ronny Gunnarsson; Sigvard Mölstad; Nils Rodhe; Lars Jonsson; Peter Ulleryd
Journal:  BMC Geriatr       Date:  2014-03-13       Impact factor: 3.921

8.  Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.

Authors:  Sebastian Bischoff; Thomas Walter; Marlis Gerigk; Matthias Ebert; Roger Vogelmann
Journal:  BMC Infect Dis       Date:  2018-01-26       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.